Generation of a Candidate Live Marker Vaccine for Equine Arteritis Virus by Deletion of the Major Virus Neutralization Domain

Por Castillo-Olivares, Javier, Wieringa, Roeland, Bakonyi, Tamás, de Vries, Antoine A. F., Davis-Poynter, Nick J., Rottier, Peter J. M.
Publicado em 2003

Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA)

Por Chiam, Rachael, Sharp, Emma, Maan, Sushila, Rao, Shujing, Mertens, Peter, Blacklaws, Barbara, Davis-Poynter, Nick, Wood, James, Castillo-Olivares, Javier
Publicado em 2009

Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus

Por de la Poza, Francisco, Calvo-Pinilla, Eva, López-Gil, Elena, Marín-López, Alejandro, Mateos, Francisco, Castillo-Olivares, Javier, Lorenzo, Gema, Ortego, Javier
Publicado em 2013

Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical prot...

Por Alberca, Berta, Bachanek-Bankowska, Katarzyna, Cabana, Marta, Calvo-Pinilla, Eva, Viaplana, Elisenda, Frost, Lorraine, Gubbins, Simon, Urniza, Alicia, Mertens, Peter, Castillo-Olivares, Javier
Publicado em 2014

A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model

Por Castillo-Olivares, Javier, Calvo-Pinilla, Eva, Casanova, Isabel, Bachanek-Bankowska, Katarzyna, Chiam, Rachael, Maan, Sushila, Nieto, Jose Maria, Ortego, Javier, Mertens, Peter Paul Clement
Publicado em 2011

Real Time RT-PCR Assays for Detection and Typing of African Horse Sickness Virus

Por Bachanek-Bankowska, Katarzyna, Maan, Sushila, Castillo-Olivares, Javier, Manning, Nicola M., Maan, Narender Singh, Potgieter, Abraham C., Di Nardo, Antonello, Sutton, Geoff, Batten, Carrie, Mertens, Peter P. C.
Publicado em 2014

Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2

Por Jabbar, Tamara Kusay, Calvo-Pinilla, Eva, Mateos, Francisco, Gubbins, Simon, Bin-Tarif, Abdelghani, Bachanek-Bankowska, Katarzyna, Alpar, Oya, Ortego, Javier, Takamatsu, Haru-Hisa, Mertens, Peter Paul Clement, Castillo-Olivares, Javier
Publicado em 2013